The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism

Gynecological Endocrinology

Volumn 17, Issue 1, 2003, Pages 57-63

  Lakryc, E M ^a   Motta, E L A ^a   Soares Jr , J M ^a   Haidar, M A ^a   Rodrigues De Lima, G ^a   Baracat, E C ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Antiandrogen; Finasteride; Idiopathic Hirsutism; Polycystic Ovary Syndrome

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; FINASTERIDE; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PLACEBO; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART RATE; HIRSUTISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; OVARY POLYCYSTIC DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0037298962     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.17.1.57.63     Document Type: Article

References (38)

1. Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol 33:640-54
2. Wagner RF. Jr. Physical methods for the management of hirsutism. Cutis 1990;45:319-21
3. Khoury MY, Baracat EC, Pardini DP, et al. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women. Fertil Steril 1994;62:76-80
4. Lima MF, Nunes MG, Bonduki CE, et al. The ACTH test in the diagnosis of hirsutism. Rev Paul Med 1997;115:1403-5
5. Rabinowitz S, Cohen R, Le Roith HD. Anxiety and hirsutism. Psychol Rep 1983;53:827-30
6. Çolak R, Kelestimur F, Ünlühizarci K, et al. A comparison between the effects of low dose (1 μg) and standard dose (250 μg) ACTH stimulation tests on adrenal p450c17α enzyme activity in women with polycystic ovary syndrome. Eur J Endocrinol 2002;147:473-7
7. Gokmen O, Senoz S, Gulekli B, et al. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome. Gynecol Endocrinol 1996;10:249-55
8. Motta EL, Baracat EC, Haidar MA, et al. Ovarian activity before and after gonadal suppression by GnRH-a in patients with polycystic ovary syndrome, hyperandrogenism, hyperinsulinism and acanthosis nigricans. Rev Assoc Med Bras 1998;44:94-8
9. Pazos F, Escobar-Morreale HF, Balsa J, et al. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism. Fertil Steril 1999;71:122-8
10. Isik AZ, Gokmen O, Zeyneloglu HB, et al. Low dose ketoconazole is an effective and a relatively safe alternative in the treatment of hirsutism. Aust N Z J Obstet Gynaecol 1996;36:487-9
11. Spritzer PM, Lisboa KO, Mattiello S, et al. Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol (Oxf) 2000;52:587-94
12. Van Wayjen RG, Van den Ende A. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects. Exp Clin Endocrinol Diabetes 1995;103:241-51
13. Muderris II, Bayram F, Sahin Y, et al. Comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism. Fertil Steril 1997;68:644-7
14. Rittmaster RS. Finasteride. N Engl J Med 1994;330:120-5
15. Stoner E. The clinical development of a 5-α reductase inhibitor, finasteride. J Steroid Biochem Mol Biol 1990;37:375-8
16. Randall VA. Androgens and human hair growth. Clin Endocrinol 1994;40:439-57
17. Rittmaster RS. Androgen conjugates: physiology and clinical significance. Endocrinol Res 1993;14:121
18. Chen W, Zouboulis CC, Orfanos CE. 5 alpha reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996;193:177-84
19. Spinucci G, Pasquali R. La finasterida: un nuovo farmaco nel trattamento dell'irsurismo e dell'alopecia androgenica maschile? Clin Ter 1996;147:305-15
20. Castello R, Tosi F, Perrone F, et al. Outcome of long-term treatment with the 5 alpha reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects and 1 year course of therapy and 1 year follow up. Fertil Steril 1996;66:734-40
21. Ciotta L, Cianci A, Calogero AE, et al. Clinical and endocrine effects of finasteride, a 5-α reductase inhibitor, in women with idiopathic hirsutism. Fertil Steril 1995;64:299-306
22. Moghetti P, Castello R, Chiara M, et al. Clinical and hormonal effects of the 5-α reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab 1994;79:1115-21
23. Tolino A, Petroni A, Sarnacchiaro F, et al. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61-5
24. Tenover JS, Stoner E, Rittmaster RS, et al. Effects of finasteride (MK-906), a 5-α reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab 1990;70:1136-41
25. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-8
26. Siegel S, Castellan NJ Jr. Nonparametric Statistics, 2nd edn. New York: McGraw-Hill, 1988
27. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley & Sons, 1973
28. Landis JR, Kock GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74
29. Gormley GJ. Finasteride: a clinical review. Biomed Pharmacol 1995;49:319-24
30. Tremblay RR. Treatment of hirsutism with spironolactone. J Clin Endocrinol Metab 1986;5:363-71
31. Hammerstein J, Meckies J, Leo-Rossberg I. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975;75:827-36
32. Tolmo A, Petrone A, Sarnacchiaro F, et al. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61-5
33. Sahin Y, Bayram F, Kelestimur F, et al. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. J Endocrinol Invest 1998;21:348-52
34. Sahin Y, Dilber S, Kelestimurm F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2001;75:496-500
35. Falsetti L, Gambera A, Platto C, et al. Management of hirsutism. Am J Clin Dermatol 2000;1:89-99
36. Serafini P, Lobo RA. Increased 5-α reductase activity in idiopathic hirsutism. Fertil Steril 1985;43:74-8
37. Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomized trial comparing low-dose flutamide, finasteride, ketoconozole and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999;84:1304-10
38. Falsetti L, Gambera A, Legrenzi L, et al. Comparison of finasteride and flutamide in the treatment of hirsutism. Eur J Endocrinol 1999;141:361-7